Back to AVIR
JPMORGAN CHASE & CO AVIR Position History
Atea Pharmaceuticals, Inc. • Healthcare
Quarters held
16
Latest value
$404K
Q2 2026
Peak value
$4.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.3M |
| Q3 2025 | $187K |
| Q3 2025 | $20K |
| Q3 2025 | $243K |
| Q4 2025 | $4.1M |
| Q4 2025 | $438K |
| Q4 2025 | $214K |
| Q4 2025 | $25K |
| Q1 2026 | $462K |
| Q1 2026 | $4.1M |
| Q1 2026 | $33K |
| Q1 2026 | $142K |
| Q2 2026 | $403K |
| Q2 2026 | $3.5M |
| Q2 2026 | $22K |
| Q2 2026 | $404K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $404K | 87.6K | — | — |
| Q2 2026 | $22K | 4.9K | — | — |
| Q2 2026 | $3.5M | 766.0K | — | — |
| Q2 2026 | $403K | 87.5K | — | — |
| Q1 2026 | $142K | 28.0K | — | — |
| Q1 2026 | $33K | 6.5K | — | — |
| Q1 2026 | $4.1M | 814.7K | — | — |
| Q1 2026 | $462K | 90.9K | — | — |
| Q4 2025 | $25K | 6.9K | — | — |
| Q4 2025 | $214K | 59.9K | — | — |
| Q4 2025 | $438K | 122.8K | — | — |
| Q4 2025 | $4.1M | 1.16M | — | — |
| Q3 2025 | $243K | 83.6K | — | — |
| Q3 2025 | $20K | 6.7K | — | — |
| Q3 2025 | $187K | 64.4K | — | — |
| Q3 2025 | $1.3M | 462.0K | — | — |